Monthly Archives: July 2013

Tendonitis

On: July 6, 2013 By: robsem Posted in Blog, Health

So, you have been diagnosed with wrist tendonitis, or fear you might develop it, and it is time to look at treatments. Preventative methods for tendonitis of the wrist are part of a comprehensive treatment program and should be exercised during and after recovery. Tendonitis can be caused by repetitive or acute trauma or a combination of the two. Treatment for tendonitis is the same whether it developed as a repetitive stress injury or not. Finding the Cause of Tendonitis The first step in treating and preventing wrist tendonitis is understanding what caused it. Many general causes of repetitive stress » » » [Read more]

Underactive Thyroid

On: July 3, 2013 By: Odessa Wilson, MD, FPCP Posted in Blog, Health

The condition of having an underactive thyroid is called hypothyroidism. This is a state of thyroid hormone deficiency or lack of thyroid hormones. It may be caused by an abnormality in the thyroid gland itself which is called primary hypothyroidism or by an insufficient level of thyroid stimulating hormone (TSH) causing under stimulation of the thyroid gland resulting to low thyroid hormone production. Underactive Thyroid Symptoms Signs and symptoms of thyroid hormone deficiency reflect the need for thyroid hormones in metabolism and its effect on all organs. Patients present with thickened features and puffy appearance. Swelling around the eyes and » » » [Read more]

A Comparative Study of the Effect of Vildagliptin and Glimepiride on Glucose Variability in Type 2 Diabetic Patients With Inadequate Glycemic Control on Metformin

On: July 1, 2013 By: Odessa Wilson, MD, FPCP Posted in Blog, Medical Journals

Authors: Odessa G. Tolentino-Wilson, M.D., FPCP Augusto D. Litonjua, M.D., FPCP, FPSEM, FACE Section of Endocrinology and Metabolism Makati Medical Center INTRODUCTION: Vildagliptin is a member of the dipeptidyl peptidase IV inhibitor (DPP-IV inhibitor) class of drugs. These drugs are believed to improve glucose variability by restoring the physiologic pattern of insulin secretion. Vildagliptin improves glycemia by improving beta and alpha cells’ sensitivity to glucose.1 This addresses the impaired glucose-mediated suppression of glucagon secretion in diabetes that results in increased hepatic glucose output and subsequently hyperglycemia.2 In a study that compared the effect of vildagliptin and glimepiride on prandial glucagon » » » [Read more]